Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alignment Healthcare (ALHC) EBITDA (2020 - 2025)

Alignment Healthcare's EBITDA history spans 6 years, with the latest figure at -$2.4 million for Q4 2025.

  • For Q4 2025, EBITDA rose 84.43% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached $44.6 million, up 154.96%, while the annual FY2025 figure was $44.6 million, 159.31% up from the prior year.
  • EBITDA reached -$2.4 million in Q4 2025 per ALHC's latest filing, down from $15.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $29.8 million in Q2 2025 to a low of -$49.0 million in Q1 2021.
  • Average EBITDA over 5 years is -$20.8 million, with a median of -$25.9 million recorded in 2023.
  • Peak YoY movement for EBITDA: crashed 3106.09% in 2021, then soared 351.0% in 2025.
  • A 5-year view of EBITDA shows it stood at -$39.4 million in 2021, then decreased by 20.4% to -$47.5 million in 2022, then increased by 23.97% to -$36.1 million in 2023, then surged by 56.38% to -$15.7 million in 2024, then soared by 84.43% to -$2.4 million in 2025.
  • Per Business Quant, the three most recent readings for ALHC's EBITDA are -$2.4 million (Q4 2025), $15.7 million (Q3 2025), and $29.8 million (Q2 2025).